Concepedia

Véronique Darsigny

VD

Statistics

Publications

7

Citations

163

H-Index

7

Active since

2006

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Université de Sherbrooke

Novartis (China)

Véronique Darsigny is an author at Novartis (United States) specializing in medicinal chemistry, drug discovery, and nicotinamide phosphoribosyltransferase.

Publications per year

2006–2025

7

Publications

7

Highly Chemoselective Formation of Aldehyde Enamines under Very Mild Reaction Conditions

Guillaume Bélanger, M. Doré, Fréderic Ménard et al. · The Journal of Organic Chemistry · 2006 · 43 citations · Full text

, , +12

A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1

Antonin Tutter, Dennis L. Buckley, Andrei A. Golosov et al. · Nature Chemical Biology · 2025 · 28 citations

, , +14

Highly Diastereoselective Synthesis of Substituted Pyrrolidines Using a Sequence of Azomethine Ylide Cycloaddition and Nucleophilic Cyclization

Guillaume Bélanger, Véronique Darsigny, M. Doré et al. · Organic Letters · 2010 · 24 citations · Full text

, , +12

A small-molecule inhibitor of C5 complement protein

Keith Jendza, Mitsunori Kato, Michael Salcius et al. · Nature Chemical Biology · 2019 · 21 citations

, , +14

Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen

Daniel S. Palacios, Erik L. Meredith, Toshio Kawanami et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 17 citations

, , +14

1–5 of 7